Your session is about to expire
← Back to Search
Self-Hypnosis for Recovery After Surgery in Female Reproductive System Cancer
N/A
Waitlist Available
Led By Larissa A Meyer
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Undergoing an exploratory laparotomy for suspected gynecologic cancer, which includes metastatic disease from neoplasia originating in other organs
Patient must be able to read, understand, and speak English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-operative day 1 (pod1)
Awards & highlights
Study Summary
This trial studies the effects of self-hypnosis on post-surgery recovery in gynecologic cancer patients.
Who is the study for?
This trial is for English-speaking patients scheduled for exploratory laparotomy due to suspected gynecologic cancer, who can participate in the Enhanced Recovery Pathway. They must be able to understand and consent to a randomized study and have no major psychiatric diseases or hearing impairments that would interfere with self-hypnosis.Check my eligibility
What is being tested?
The trial is testing if self-hypnosis can improve recovery after surgery for gynecologic cancer. Patients will use guided relaxation techniques aimed at reducing pain and discomfort post-surgery. The effectiveness of this method will be compared against standard care practices.See study design
What are the potential side effects?
Self-hypnosis is generally considered safe with minimal risk of side effects. However, it may not be suitable for individuals with certain psychiatric conditions or those who are unable to hear the guided instructions properly.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am having surgery to explore for suspected cancer in my reproductive organs.
Select...
I can read, understand, and speak English.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post-operative day 1 (pod1)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-operative day 1 (pod1)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility of participating in pre-operative self-hypnosis
Patients' perception of post-surgical pain
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm II (usual care, self-hypnosis guided relaxation)Experimental Treatment4 Interventions
Patients receive usual care as in Arm I. Patients also receive self-hypnosis guided relaxation by listening to MP3 on the ERAS pathway.
Group II: Arm I (usual care)Active Control3 Interventions
Patients receive usual care including receipt of multi-modal analgesia and the injection of a local analgesic at the time of surgery on the ERAS pathway.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hypnotherapy
2016
Completed Phase 3
~810
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
2,967 Previous Clinical Trials
1,804,650 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,515 Total Patients Enrolled
Larissa A MeyerPrincipal InvestigatorM.D. Anderson Cancer Center
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger